CLINICAL RESEARCH: CARDIAC IMAGING
Reproducibility of Chronic and Acute Infarct Size Measurement by Delayed Enhancement-Magnetic Resonance Imaging
Holger Thiele, MD*,*,
Mathias J.E. Kappl, MD*,
Stefan Conradi, MD ,
Josef Niebauer, MD, PhD*,
Rainer Hambrecht, MD* and
Gerhard Schuler, MD*
* Department of Cardiology, University of Leipzig-Heart Center, Leipzig, Germany
Department of Radiology, University of Leipzig-Heart Center, Leipzig, Germany
Manuscript received May 11, 2005;
revised manuscript received October 31, 2005,
accepted November 16, 2005.
* Reprint requests and correspondence: Dr. Holger Thiele, Department of Internal Medicine/Cardiology, University of Leipzig-Heart Center, Strümpellstr. 39, 14289 Leipzig, Germany. (Email: thielh{at}medizin.uni-leipzig.de).
OBJECTIVES: The aim of this study was to evaluate the reproducibility of acute and chronic infarct size (IS) by delayed enhancement (DE) magnetic resonance imaging (MRI).
BACKGROUND: Infarct size measurements can be used as surrogate end point to reduce the sample size in studies comparing different reperfusion strategies in myocardial infarction (MI). Delayed enhancement MRI is a rather new technique, and so far infarct IS reproducibility has not been established appropriately.
METHODS: In 21 patients (10 acute MI and 11 chronic MI), IS was assessed repeatedly on consecutive days by DE-MRI. Reproducibility, interobserver, and intraobserver variabilities were assessed and compared by the Bland-Altman method.
RESULTS: Acute and chronic IS were 17.1 ± 19.6% (range 5.1% to 69.8%) of LV mass (%LV) and 16.9 ± 9.9 %LV (range 2.0% to 36.0%), respectively. Infarct size difference (bias) between scan I and scan II was –0.5 %LV, and limits of agreement were ±2.4 %LV. Mean bias (–0.7 %LV) and limits of agreement (±3.2%) were slightly higher for acute in comparison with chronic MI with –0.4 ± 1.3 %LV. Intraobserver and interobserver variability was low with a mean bias of 0.3 %LV (limits of agreement ± 1.7 %LV) and –0.7 %LV (limits of agreement ± 2.2 %LV), respectively.
CONCLUSIONS: Infarct size measurement by DE-MRI is an excellent tool for IS assessment, owing to its excellent repeatability in chronic and acute MI. It has therefore the potential to serve as a surrogate end point to uncover advantages of new reperfusion strategies.
|
Abbreviations and Acronyms
| | DE = delayed enhancement | | IR = inversion-recovery | | IS = infarct size | | LV = left ventricle/ventricular | | MI = myocardial infarction | | MRI = magnetic resonance imaging | | %LV = percentage infarct size of left ventricular mass | | SPECT = single-photon emission computed tomography |
|
This article has been cited by other articles:
|
|
|
|
 
H. Kitabata, T. Imanishi, T. Kubo, S. Takarada, M. Kashiwagi, H. Matsumoto, H. Tsujioka, H. Ikejima, Y. Arita, K. Okochi, et al.
Coronary Microvascular Resistance Index Immediately After Primary Percutaneous Coronary Intervention as a Predictor of the Transmural Extent of Infarction in Patients With ST-Segment Elevation Anterior Acute Myocardial Infarction.
J. Am. Coll. Cardiol. Img.,
March 1, 2009;
2(3):
263 - 272.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Thiele, J. Friedenberger, I. Eitel, G. Furnau, E. Grebe, S. Erbs, A. Linke, S. Mobius-Winkler, G. Schuler, K. Schindler, et al.
Response to Letter Regarding Article, "Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention"
Circulation,
January 27, 2009;
119(3):
e20 - e20.
[Full Text]
[PDF]
|
|
|
|
|
|
|
D. H. Kwon, C. M. Halley, T. P. Carrigan, V. Zysek, Z. B. Popovic, R. Setser, P. Schoenhagen, R. C. Starling, S. D. Flamm, and M. Y. Desai
Extent of left ventricular scar predicts outcomes in ischemic cardiomyopathy patients with significantly reduced systolic function: a delayed hyperenhancement cardiac magnetic resonance study.
J. Am. Coll. Cardiol. Img.,
January 1, 2009;
2(1):
34 - 44.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Engblom, E. Hedstrom, E. Heiberg, G. S. Wagner, O. Pahlm, and H. Arheden
Rapid Initial Reduction of Hyperenhanced Myocardium After Reperfused First Myocardial Infarction Suggests Recovery of the Peri-Infarction Zone: One-Year Follow-Up by MRI
Circ Cardiovasc Imaging,
January 1, 2009;
2(1):
47 - 55.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Eitel, F. Behrendt, K. Schindler, D. Kivelitz, M. Gutberlet, G. Schuler, and H. Thiele
Differential diagnosis of suspected apical ballooning syndrome using contrast-enhanced magnetic resonance imaging
Eur. Heart J.,
November 1, 2008;
29(21):
2651 - 2659.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Thiele, K. Schindler, J. Friedenberger, I. Eitel, G. Furnau, E. Grebe, S. Erbs, A. Linke, S. Mobius-Winkler, D. Kivelitz, et al.
Intracoronary Compared With Intravenous Bolus Abciximab Application in Patients With ST-Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention: The Randomized Leipzig Immediate Percutaneous Coronary Intervention Abciximab IV Versus IC in ST-Elevation Myocardial Infarction Trial
Circulation,
July 1, 2008;
118(1):
49 - 57.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. S.H. Cheng, J. B. Selvanayagam, M. Jerosch-Herold, W. J. van Gaal, T. D. Karamitsos, S. Neubauer, and A. P. Banning
Percutaneous treatment of chronic total coronary occlusions improves regional hyperemic myocardial blood flow and contractility insights from quantitative cardiovascular magnetic resonance imaging.
J. Am. Coll. Cardiol. Intv.,
February 1, 2008;
1(1):
44 - 53.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
H. Thiele, M. J. Kappl, A. Linke, S. Erbs, E. Boudriot, A. Lembcke, D. Kivelitz, and G. Schuler
Influence of time-to-treatment, TIMI-flow grades, and ST-segment resolution on infarct size and infarct transmurality as assessed by delayed enhancement magnetic resonance imaging
Eur. Heart J.,
June 6, 2007;
(2007)
ehm173v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
T. F. Christian
Positively Magnetic North
J. Am. Coll. Cardiol.,
April 18, 2006;
47(8):
1646 - 1648.
[Full Text]
[PDF]
|
|
|
|
